[ Price : $8.95]
Federal Register notice: FDA determines that Takedas Trintellix (vortioxetine hydrobromide) oral tablet, indicated for treating ma...[ Price : $8.95]
Federal Register notice: FDA seeks comments on an information collection extension for its guidance on Notification of the Intent ...[ Price : $8.95]
FDA approves a ViiV Healthcare NDA for Juluca, the first complete treatment regimen containing two drugs to treat certain adults w...[ Price : $8.95]
Stakeholders ask FDA for greater clarification on elements in its proposed framework for drug benefit-risk analysis.[ Price : $8.95]
The House Commerce Subcommittee on Health announces an 11/30 hearing on Implementing the 21st Century Cures Act: An Update from FD...[ Price : $8.95]
Three industry representatives take different approaches to FDA efforts to restore a balance between innovation and generic drug a...[ Price : $8.95]
FDA warns Chinas Hubei Pharmaceutical Co. about CGMP violations in its production of active pharmaceutical ingredients.[ Price : $8.95]
Genentech says a Pfizer biosimilar to its Herceptin will infringe 40 Genentech patents and should be barred by a federal court inj...